Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Angela Rivers, MD, PhD
Researcher Assistant Professor
Division of Hematology/Oncology
University of Illinois College of Medicine
Outpatient Care Center, Suite 2E
1801 West Taylor Street
Chicago, Illinois, United States
Dr. Rivers is the Director at Sickle Cell Transition Adolescent-Adult Readiness Clinic (STAR) program. Her research interests focus on the Adeno Associated Virus as a vector for gene therapy in sickle cell disease. She has received NIH K08 funding for lab research inducers of fetal hemoglobin. The research (K01 HL103172-01, NIH/ NIHLBI) led by Dr. Rivers focuses on AAV capsid engineering to facilitate expression of therapeutic levels of beta-globin in mouse hematopoietic stem cells. Because everyone is not a candidate for transplantation, successful treatment for sickle cell disease needs to include the development of therapeutic options beside hydroxyurea. Under the mentorship of Dr. Don Lavelle and Dr. Joseph De Simone at the University of Illinois Chicago, the research of Dr. Rivers also focuses on the possible phenotypic correction of sickle disease by induction of hemoglobin F with the combination treatment of Decitabine and novel drugs.
Representative Publications:
+myBinderRelated Content
-
MARAC Statement: Health Insurance Coverage for Hematopoietic Stem Cell Transplant for Sickle Cell Disease from HLA-m...Hematopoietic stem cell transplant for s...
-
Improving Sickle Cell Transitions of Care Through Health Information TechnologyINTRODUCTION: Transitions between inpati...
-
Kenneth R. Peterson, PhDKenneth R. Peterson is the Professor and...
-
University of Illinois HospitalThe Sickle Cell Program at UI Health is ...
-
Newark Beth Israel Medical CenterNewark Beth Israel Medical Center treats...
-
Carolyn C. Hoppe, MDDr. Hoppe is a senior clinician and scie...
-
Opioid Abuse Backlash Could Hurt Sickle Cell Patients’ Medication Needs, Some FearWith drug overdoses now the leading caus...
